Emily Leproust Net Worth and Financial Overview
Emily Leproust is a French-born chemist, entrepreneur, and executive best known for cofounding and leading a synthetic biology company that manufactures synthetic DNA and RNA. Her net worth is tied to her equity stake in the company, its public valuation, and her compensation as CEO. Estimates place her among the notable biotech founders whose wealth is driven by company performance, venture backing, and public market movements Forbes.
The primary source of Emily Leproust net worth is her role as cofounder and chief executive officer of Twist Bioscience, a publicly traded company that synthesizes custom DNA and RNA for customers in genomics, drug discovery, and industrial biotech. Her personal wealth fluctuates with the company share price, insider sales, and broader biotech market conditions. Financial disclosures and investor materials provide the most direct data points on her holdings and compensation SEC.
Career Milestones and Companies
Twist Bioscience Leadership
Emily Leproust cofounded Twist Bioscience in 2013 and has served as CEO since the company's early stages. Under her leadership, the company built a platform for high-throughput DNA synthesis and expanded into RNA manufacturing. Twist went public through a direct listing, and its market capitalization has made it a notable player in the synthetic biology sector Twist Bioscience Investor Relations.
Prior Industry Experience
Before Twist Bioscience, Emily Leproust held research and management roles in the biotech and chemical industries. Her academic background in chemistry and her work in genomics-focused companies helped shape the technical direction of Twist. These roles contributed to the expertise and industry relationships that supported the company's growth and fundraising Bloomberg.
Key Facts, Rankings, and Recent Developments
Company Performance and Market Standing
Twist Bioscience is recognized as a leading provider of synthetic DNA and RNA, serving customers across genomics, diagnostics, and therapeutics. The company's revenue growth, partnerships, and product launches are closely watched by investors and analysts. Emily Leproust's net worth is often discussed alongside Twist's valuation and its position among public biotech companies BusinessWire.
Public Profile and Recognition
Emily Leproust has been featured in business and technology media as a prominent biotech founder and CEO. Her public profile includes speaking engagements, industry awards, and inclusion in lists of influential leaders in life sciences and entrepreneurship. These recognitions reflect the visibility and influence associated with her role at Twist Bioscience and the broader synthetic biology field.